CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer.

by kira@rippkedesign.com | Nov 1, 2021 | Data Papers, Journal Publications

Morra F, Merolla F, Criscuolo D, Insabato L, Giannella R, Ilardi G, Cerrato A, Visconti R, Staibano S, Celetti A.J Exp Clin Cancer Res. 2019 Feb 20;38(1):90. doi: 10.1186/s13046-019-1087-1.PMID: 30786932 Free PMC article.

New combinatorial strategies to improve the PARP inhibitors efficacy in the urothelial bladder Cancer treatment.

by kira@rippkedesign.com | Nov 1, 2021 | Data Papers, Journal Publications

Criscuolo D, Morra F, Giannella R, Visconti R, Cerrato A, Celetti A.J Exp Clin Cancer Res. 2019 Feb 22;38(1):91. doi: 10.1186/s13046-019-1089-z.PMID: 30791940 Free PMC article. Review.

Cardioprotective Effect of Phase 3 Clinical Anticancer Agent, RRx-001, in Doxorubicin-Induced Acute Cardiotoxicity in Mice.

by kira@rippkedesign.com | Nov 1, 2021 | Data Papers, Journal Publications

Oronsky B, Ao-Ieong ESY, Yalcin O, Carter CA, Cabrales P.Mol Pharm. 2019 Jul 1;16(7):2929-2934. doi: 10.1021/acs.molpharmaceut.9b00150. Epub 2019 Jun 3.PMID: 31038318

RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer.

by kira@rippkedesign.com | Nov 1, 2021 | Data Papers, Journal Publications

Morgensztern D, Rose M, Waqar SN, Morris J, Ma PC, Reid T, Brzezniak CE, Zeman KG, Padmanabhan A, Hirth J, I Spira A, Trepel JB, Padda SK.Br J Cancer. 2019 Jul;121(3):211-217. doi: 10.1038/s41416-019-0504-8. Epub 2019 Jun 24.PMID: 31231122 Free PMC...

RRx-001 protects normal tissues but not tumors via Nrf2 induction and Bcl-2 inhibition.

by kira@rippkedesign.com | Nov 1, 2021 | Data Papers, Journal Publications

Oronsky B, Scribner C, Aggarwal R, Cabrales P.J Cancer Res Clin Oncol. 2019 Aug;145(8):2045-2050. doi: 10.1007/s00432-019-02958-4. Epub 2019 Jun 27.PMID: 31250159